TABLE 1

Patient characteristics

OverallNon-hospitalisedHospitalisedp-value hospitalised versus non-hospitalised
Demographics572334
Age years51 (13)41 (12)57 (10)<0.001
Male sex n (%)28 (49)7 (30)21 (61)0.040
Race or ethnic group0.206
 Caucasian n (%)44 (77)19 (83)25 (74)
 Asian n (%)2 (4)2 (9)0 (0.0)
 African n (%)2 (4)0 (0.0)2 (6)
 Indian n (%)1 (2)0 (0.0)1 (3)
 Middle Eastern n (%)8 (14.0)2 (8.7)6 (18)
BMI kg·m−22726290.095
BMI >30 kg·m−2 n (%)12 (26)3 (14)9 (36)0.182
Smoking0.442
 Current smoker n (%)1 (2)1 (4)0 (0.0)
 Previous smoker n (%)22 (39)8 (35)14 (41)
Time since cessation years17 (15)18 (11)17 (17)0.901
Work status0.023
 Working n (%)45 (79)22 (96)23 (68)
 Currently out of work n (%)3 (5)1 (4)2 (6)
 Retired n (%)9 (16)0 (0.0)9 (27)
Comorbidities
 Charlson Morbidity Index2.26 (2.26)1.00 (1.00)3.12 (2.47)<0.001
 Diabetes mellitus n (%)5 (9)0 (0.0)5 (15)0.148
 Moderate to severe CKD n (%)2 (4)0 (0.0)2 (6)0.652
 COPD n (%)2 (4)0 (0.0)2 (6)0.652
 Asthma n (%)15 (26)4 (17)11 (32)0.341
Acute COVID-19 severity
 Mean days in the hospital days013.3 (21.9)
 Oxygen therapy n (%)021 (61.8)
 Maximum oxygen L·min−1 of those on oxygen20 (19.6)
 Oxygen >0 and <5 L·min−1 n (%)7 (20.6)
 Oxygen >5 and <15 L·min−1 n (%)4 (11.8)
 HFNC n (%)9 (26.5)
 Intubation n (%)1 (2.9)
 Maximum ferritin µg·L−1NA1340 (440–2295)
 Minimum lymphocytes ×109·L−1NA0.9 (0.7–1.3)
 Maximum CRP mg·L−1NA153 (84–203)
 Maximum LDH U·L−1NA376 (259–531)
 Procalcitonin µg·L−1NA0.16 (0.10–0.66)
 Maximum D-dimer FEU·L−1NA0.87 (0.72–1.65)
  • Data is presented as mean (standard deviation) or n (percentage).

  • BMI: body mass index; CKD: chronic kidney disease; HFNC: high-flow nasal continuous positive airway pressure; CRP: C-reactive protein; LDH: lactate dehydrogenase; NA: not available.